Loading of propranolol hydrochloride on mcf and sustained release

被引:0
|
作者
Li X.-D. [1 ]
Zhai Q.-Z. [2 ]
机构
[1] Department of Basic Science, Jilin Jianzhu University, 5088 Xincheng Street, Changchun
[2] Research Center for Nanotechnology, Changchun University of Science and Technology, 7186 Weixing Road, Changchun
关键词
Nanometer mesoporous MCF; Propranolol hydrochloride; Simulated body fluid; Simulated gastric juice; Simulated intestinal fluid; Sustained release;
D O I
10.2174/1876402912999200608141217
中图分类号
学科分类号
摘要
Aims: Adsorption conditions of propranolol hydrochloride onto MCF are optimized. Properties of this adsorption system are studied. The sustained release properties of propranolol hydrochloride in the loading system are also researched. Background: In today's society, demand for drugs is getting higher and higher. With the development of nanotechnology, it is easier to immobilize drugs on nanomaterials, which can easily transport drugs in the human body. It can control drug release, reduce side effects, improve drug efficacy, and develop drug orientation. Objective: The purpose of this study was to load propranolol hydrochloride, a drug for the treatment of heart disease and hypertension on the MCF nano-mesoporous material to prepare a sustainedrelease preparation and investigate the release law of propranolol hydrochloride in simulated human body fluid. Method: Nanometer mesoporous MCF (mesocellular foams) silica material was prepared in acidic medium using triblock copolymer poly(ethylene glycol)-block-poly(propyl glycol)-blockpoly(ethylene glycol) as template and tetraethoxysilane as silica source. Propranolol hydrochloride drug was incorporated into the MCF mesoporous material by the impregnation method to prepare MCF-propranol hydrochloride host-guest composite material. The loading amount of drug was calculated by spectrophotometry and difference subtraction method. Results: The loading amount of drug calculated by spectrophotometry and difference subtraction method was 385.5 mg·g-1 (propranolol hydrochloride/MCF). The adsorption process of propranolol hydrochloride in MCF belongs to the quasi-second-order kinetic process. Adsorption process ΔH0 = 19.11 kJ·mol-1, is an exothermic process, ΔG0 < 0, the adsorption process is a spontaneous process. The effective release time of drug lasted up to 32 h and the maximum cumulative released amount was 99.4 % through the experiment of drug sustained release in the simulated body fluid. In the simulated gastric juice, the release time of drug reached 6 h, and the maximum cumulative released amount was 56.6 %. When drug release time arrived at 10 h in the simulated intestinal fluid, the maximum cumulative released amount was 71.3 %. Conclusion: The influence of the release rate of propranolol hydrochloride molecules from MCF mesopores was demonstrated, since it results in a very slow drug delivery from the nanocomposite system. Thus, it is concluded that the prepared MCF is an efficient drug sustained-released carrier. © 2021 Bentham Science Publishers.
引用
收藏
页码:109 / 118
页数:9
相关论文
共 50 条
  • [21] SUSTAINED RELEASE ITOPRIDE HYDROCHLORIDE MATRIX TABLET
    Prajapati, Bhupendra G.
    Patel, Niklesh
    Patel, Hitesh K.
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2010, 2 (01) : 72 - 80
  • [22] Sustained-release formulation of sarpogrelate hydrochloride
    Hye Jin Kim
    Dae Hwan Shin
    Eun Ah Lim
    Jin-Seok Kim
    Archives of Pharmacal Research, 2015, 38 : 35 - 41
  • [23] Sustained-release formulation of sarpogrelate hydrochloride
    Kim, Hye Jin
    Shin, Dae Hwan
    Lim, Eun Ah
    Kim, Jin-Seok
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (01) : 35 - 41
  • [24] IN-VITRO RELEASE OF PROPRANOLOL HYDROCHLORIDE FROM TOPICAL VEHICLES
    SMITH, EW
    HAIGH, JM
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1994, 58 (03) : 306 - 309
  • [25] An approach to controlled-release dosage form of propranolol hydrochloride
    Mohammadi-Samani, S
    Adrangui, M
    Siahi-Shadbad, MR
    Nokhodchi, A
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (01) : 91 - 94
  • [26] Formulation and Evaluation of Polysaccharide Microparticles for the Controlled Release of Propranolol Hydrochloride
    Stojmenovski, Aneta
    Gataric, Biljana
    Vucen, Sonja
    Railic, Maja
    Krstonosic, Veljko
    Kukobat, Radovan
    Mirjanic, Maja
    Skrbic, Ranko
    Racic, Andelka
    PHARMACEUTICS, 2024, 16 (06)
  • [27] PREPARATION AND EVALUATION OF CONTROLLED-RELEASE PROPRANOLOL HYDROCHLORIDE BEADS
    HOSNY, EA
    ELMAHROUK, GM
    ALANGARY, A
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (06) : 1085 - 1091
  • [28] Formulation and in vitro Characterization of Time Release Tablets of Propranolol Hydrochloride
    Giri, S.
    Mohapatra, S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 (02) : 216 - 221
  • [30] FORMULATION AND EVALUATION OF SUSTAINED RELEASE AMBROXOL HYDROCHLORIDE MICROSPHERES
    Dhot, Rupinder
    Singh, Karambir
    Shaheeda
    Shabbeer, Shaik
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (05): : 1466 - 1474